NAADI Healthcare
Welcome,         Profile    Billing    Logout  
 2 Trials 
5 Trials

   Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Parker, Robert Lamar
NCT05399641: Ibrexafungerp for the Treatment of Complicated Vulvovaginal Candidiasis

Completed
3
150
US
Ibrexafungerp
Scynexis, Inc.
Vulvovaginal Candidiasis
05/23
08/23
MERMAID, NCT06121063: CCT-102 or Expectant Management in Delayed Pregnancy Loss

Active, not recruiting
3
183
US
CCT-102 A and CCT-102 B
Conceptra Biosciences, LLC
Early Pregnancy Loss, Delayed Pregnancy Loss
05/25
05/25
NCT05289557: The Efficacy and Safety of Bonjesta® for Nausea and Vomiting of Pregnancy in Pregnant Adolescents

Recruiting
3
274
US
Bonjesta, Placebo
Duchesnay Inc., Health Decisions
Morning Sickness
12/27
12/27
ELENA, NCT05560646: A Study to Investigate Efficacy and Safety of OG-6219 BID in 3 Dose Levels Compared With Placebo in Participants Aged 18 to 49 With Moderate to Severe Endometriosis-related Pain

Completed
2
354
Europe, US, RoW
OG-6219, Placebo
Organon and Co, Iqvia Pty Ltd
Endometriosis
05/25
05/25
NCT05913609: Safety and Effectiveness of the Yaari Extractor for Management of Shoulder Dystocia

Recruiting
N/A
80
US
Yaari Extractor
FetalEase Ltd.
Shoulder Dystocia
11/25
04/26
Miller, Jami
No trials found
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Parker, Robert Lamar
NCT05399641: Ibrexafungerp for the Treatment of Complicated Vulvovaginal Candidiasis

Completed
3
150
US
Ibrexafungerp
Scynexis, Inc.
Vulvovaginal Candidiasis
05/23
08/23
MERMAID, NCT06121063: CCT-102 or Expectant Management in Delayed Pregnancy Loss

Active, not recruiting
3
183
US
CCT-102 A and CCT-102 B
Conceptra Biosciences, LLC
Early Pregnancy Loss, Delayed Pregnancy Loss
05/25
05/25
NCT05289557: The Efficacy and Safety of Bonjesta® for Nausea and Vomiting of Pregnancy in Pregnant Adolescents

Recruiting
3
274
US
Bonjesta, Placebo
Duchesnay Inc., Health Decisions
Morning Sickness
12/27
12/27
ELENA, NCT05560646: A Study to Investigate Efficacy and Safety of OG-6219 BID in 3 Dose Levels Compared With Placebo in Participants Aged 18 to 49 With Moderate to Severe Endometriosis-related Pain

Completed
2
354
Europe, US, RoW
OG-6219, Placebo
Organon and Co, Iqvia Pty Ltd
Endometriosis
05/25
05/25
NCT05913609: Safety and Effectiveness of the Yaari Extractor for Management of Shoulder Dystocia

Recruiting
N/A
80
US
Yaari Extractor
FetalEase Ltd.
Shoulder Dystocia
11/25
04/26
Miller, Jami
No trials found

Download Options